Evaluation of the Safety and Efficacy of the CardioPulseTM PuLsed fiEld Ablation SystEm in Patients With Paroxysmal Atrial Fibrillation (PLEASE-AF Study)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 158 participants.
Also called NCT05114954
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 158 participants
- Registry
-
NCT05114954
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05114954. Allocation not applicable; no masking; primary purpose treatment. Start 2021-10-27 (actual); primary completion 2022-06-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the Safety and Efficacy of the CardioPulseTM PuLsed fiEld Ablation SystEm in Patients With Paroxysmal Atrial Fibrillation (PLEASE-AF Study)
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- CardioPulsesTM pulsed field ablation system
- Lead sponsor
- Hangzhou Dinova EP Technology Co., Ltd
Record details
- Record id
cardio:ct-nct05114954- Content hash
779801979e6fc688443225ea9d1418d3e60657c922adfeaa647a8943cc67a048